DaVita Investor Buys 48.8K Shares and 4 Insider Trades Not to Miss

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

ARZBAECHER ROBERT C who is Director at CF Industries Holdings, Inc. (NYSE:CF), sold 563 shares at $197.29 per share for a total value of $111,075. The shares recently traded at $197.27, down $0.02, or 0.01% since the insider sale.

MCCOLLUM LEE who is Director at Sigma-Aldrich Corporation (NASDAQ:SIAL), sold 8,000 shares at $69.76 per share for a total value of $558,084. The shares recently traded at $69.42, down $0.34, or 0.49% since the insider sale.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

KENNEDY KOLLEEN T who is SVP and Pres. Oncology Sys. at Varian Medical Systems Inc. (NYSE:VAR), sold 7,685 shares at $68.51 per share for a total value of $526,464. The shares recently traded at $68.28, down $0.23, or 0.34% since the insider sale.

BERKSHIRE HATHAWAY INC who is 10% Owner at DaVita, Inc. (NYSE:DVA), bought 48,874 shares at $112.84 per share for a total value of $5,514,805. The shares recently traded at $112.61, down $0.23, or 0.2% since the insider buy.

Brinker Scott M who is EVP – Investments at Health Care REIT Inc. (NYSE:HCN), sold 1,000 shares at $59.03 per share for a total value of $59,034. The shares recently traded at $59.37, up $0.34, or 0.58% since the insider sale.

Don’t Miss: Is Home Depot Building a Bullish Stance on Housing?

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business